Similar articles

• [Uterine pathology in women with breast cancer treated with tamoxifen].

  Carcangiu ML. Carcangiu ML. Pathologica. 1997 Jun;89(3):223-33. Pathologica. 1997. PMID: 9380417 Italian. No abstract available.
• Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.

  Vogel VG. Vogel VG. Clin Cancer Res. 2001 Dec;7(12 Suppl):4413s-4418s; discussion 4411s-4412s. Clin Cancer Res. 2001. PMID: 11916233 Review.
• [Tamoxifen in the adjuvant setting for breast cancer: Reflexions about the risk of uterine carcinosarcoma].

  Leung F, Terzibachian JJ, Govyadovskiy A, Bourtembourg A, Maillet R, Riethmuller D. Leung F, et al. Gynecol Obstet Fertil. 2009 May;37(5):447-51. doi: 10.1016/j.gyobfe.2009.03.010. Epub 2009 Apr 25. Gynecol Obstet Fertil. 2009. PMID: 19394886 French.
• Should you be taking tamoxifen?

  [No authors listed] [No authors listed] Johns Hopkins Med Lett Health After 50. 2001 Jun;13(4):4-5. Johns Hopkins Med Lett Health After 50. 2001. PMID: 11439691 No abstract available.
• Tamoxifen in cancer therapy: minireview.

  Novotny L, Rauko P, Vachálková A, Peterson-Biggs M. Novotny L, et al. Neoplasma. 2000;47(1):3-7. Neoplasma. 2000. PMID: 10870680 Review.